The epidemiology of Paenibacillus lautus infection still needs to be explored, primarily due to frequent misidentifications as Bacillus species using conventional methods. Limited data gleaned from documented cases shed light on its occurrence, revealing instances predominantly in individuals with underlying health conditions or prosthetic implants.
The first reported case of P. lautus bacteremia dates back to 1996, involving a 69-year-old man with diabetes and coronary artery disease equipped with a prosthetic aortic valve. Since then, only sporadic cases have surfaced globally, with the latest recorded instance in 2019 featuring a 65-year-old woman with diabetes and chronic kidney disease-carrying a peritoneal dialysis catheter.
Despite the scarcity of documented cases, the prevalence &incidence of P. lautus infection remain elusive, lacking a dedicated surveillance system or reporting mandate for this organism. Notably, there have been no reported outbreaks of P. lautus infection in humans, suggesting a limited virulence or transmissibility profile. However, its potential impact on public health emerges from its demonstrated resistance to various antibiotics, including penicillin, cephalosporins, and aminoglycosides.
Kingdom: Bacteria
Phylum: Bacillota
Class: Bacilli
Order: Bacillales
Family: Paenibacillaceae
Genus:Paenibacillus
Species:P. lautus
P. lautus, characterized as a gram-positive bacterium, exhibits distinctive features in its structural composition. This endospore-forming rod is typically encountered in diverse environments such as soil, water, and vegetable matter.
Microscopically, P. lautus manifests as a rod with a width ranging from 0.5 to 1.0 µm and a length spanning 4.0 to 7.0 µm. The bacterium is often observed as individual cells or arranged in pairs.
When cultivated, P. lautus forms colonies with specific characteristics. These punctiform colonies are transparent and exhibit a milky white color, featuring an entire margin and a glossy, convex surface. Additionally, the bacterium demonstrates the ability to generate subterminal ellipsoidal spores, a distinctive reproductive feature. The swelling of sporangia during spore formation contributes to the distinct morphology of P. lautus.
P. lautus exhibits antigenic diversity, categorized into two types, A and B, based on serological reactions involving its S-layer protein. This classification enhances our understanding of its immunological characteristics.
The bacterium shares substantial genetic similarities with other members of the Paenibacillus genus, including polymyxa, P. alvei, and P. thiaminolyticus, as well as certain Bacillus species. P. lautus possesses a repertoire of genes encoding enzymes crucial for the degradation of various polysaccharides such as chitin, cellulose, xylan, and starch, reflecting its versatile metabolic capabilities.
The type strain of P. lautus, isolated from the intestinal tract of a child, serves as a reference with culture collection numbers DSM 3035, LMG 11157, NRRL NRS-666, ATCC 43898, CIP 103118, JCM 9073, among others. This strain, characterized as an aerobe and mesophilic gram-positive rod, demonstrates its adaptability to oxygen and moderate temperatures. Notably, the ability to form subterminal ellipsoidal spores adds to its physiological versatility.
The pathogenesis of Paenibacillus lautus in humans remains a subject of limited understanding, given its status as a rare and opportunistic bacterial pathogen capable of causing diverse infections, including wound infection, sepsis, and endocarditis. Several potential factors contribute to its pathogenicity.First, the organism’s ability to produce endospores that exhibit resilience against heat, desiccation, and disinfectants enables it to endure harsh environments.
Additionally, P. lautus can form biofilms, providing a protective shield against antibiotics and the host immune system. The secretion of various virulence proteins, such as proteases, lipases, and hemolysins, further enhances its pathogenic potential. The bacterium’s motility factors, including swimming and swarming capabilities, play a role in facilitating invasion and dissemination.
The pathogenicity of P. lautus may be influenced by host susceptibility, with factors such as underlying health conditions, prosthetic implants, or compromised immunity contributing to its virulence. However, a comprehensive analysis of the molecular mechanisms and host-pathogen interactions underlying P. lautus infection necessitates further research.
Innate defenses include physical barriers like the skin and mucous membranes, complemented by cellular and molecular elements such as phagocytes, complement proteins, cytokines, and antimicrobial peptides. When encountering P. lautus in the bloodstream, phagocytes, particularly neutrophils and macrophages, recognize the bacteria through pattern recognition receptors (PRRs) on their surface. These receptors bind to pathogen-associated molecular patterns (PAMPs) on the bacterial cell wall, initiating phagocytic activation.
Phagocytes then engage in bacterial engulfment and destruction through oxidative and non-oxidative mechanisms, releasing pro-inflammatory cytokines like interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6). These cytokines attract more immune cells to the infection site and induce responses like fever, vasodilation, and increased vascular permeability.
B cells produce antibodies that bind to bacterial antigens, neutralizing them or facilitating phagocytosis and complement activation. Simultaneously, T cells, including helper T cells (Th) and cytotoxic T cells (Tc), are activated. Th cells release cytokines that stimulate various immune cells, while Tc cells eliminate infected cells through the release of perforin and granzymes.
Additionally, the complement system, a group of plasma proteins, is activated in the presence of bacteria. It enhances phagocytic activity, opsonizes P. lautus, and forms membrane attack complexes (MACs) that lyse bacterial cells. The adaptive immune system comes into play with humoral and cellular immunity.
Paenibacillus lautus has been implicated in causing diverse clinical manifestations in individuals with underlying health conditions such as diabetes, coronary artery disease, or those with prosthetic implants. The reported clinical outcomes associated with P. lautus infection include wound infections, cases of sepsis, and even endocarditis. These infections can vary widely in their presentation, with manifestations ranging from paucisymptomatic cases to severe sepsis. The bacterium is often detected in the bloodstream, leading to manifest bacteremia.
Healthcare providers must remain vigilant, especially when dealing with patients who have predisposing factors like diabetes, coronary artery disease, or implanted devices, as they may be more susceptible to P. lautus infections. Timely recognition & appropriate management are paramount in mitigating the impact of such infections, ranging from localized wound issues to potentially life-threatening systemic conditions like sepsis and endocarditis.
Diagnosis tests for P. lautus involve various approaches, ensuring accurate identification of this opportunistic pathogen. Molecular techniques, such as 16S rDNA sequencing, serve as powerful tools for amplifying & sequencing the highly conserved 16S ribosomal RNA gene. This method enables precise identification at the genus and species levels, contributing to the differentiation of P. lautus from other bacterial species.
Another molecular approach, ctpA sequencing, targets the ctpA gene, which encodes a protease involved in sporulation and germination. This specific gene becomes crucial for distinguishing P. lautus from closely related species. By utilizing molecular techniques, healthcare professionals can enhance the accuracy of identification, facilitating targeted and effective treatment strategies.
Complementing molecular methods, conventional biochemical tests play a crucial role in diagnosing P. lautus infections. These tests assess the metabolic and enzymatic activities of the bacteria, including catalase, oxidase, indole, nitrate reduction, and carbohydrate fermentation. The information obtained from these tests provides valuable phenotypic characteristics, reinforcing the confirmation of the bacterial identification.
Individuals should refrain from direct contact with soil, water, and vegetable matter that may harbor P. lautus spores. Protective gloves & clothing should be worn when handling potentially contaminated materials.
It is essential to practice good wound care hygiene. Any wounds or injuries should be promptly cleaned and disinfected to prevent bacterial entry. In the event of signs of infection, such as fever, pain, swelling, or pus formation, individuals should seek immediate medical attention.
Implementing measures to improve waste disposal practices & rodent control helps prevent the attraction and proliferation of rodents that may carry P. lautus-infected ticks.
The epidemiology of Paenibacillus lautus infection still needs to be explored, primarily due to frequent misidentifications as Bacillus species using conventional methods. Limited data gleaned from documented cases shed light on its occurrence, revealing instances predominantly in individuals with underlying health conditions or prosthetic implants.
The first reported case of P. lautus bacteremia dates back to 1996, involving a 69-year-old man with diabetes and coronary artery disease equipped with a prosthetic aortic valve. Since then, only sporadic cases have surfaced globally, with the latest recorded instance in 2019 featuring a 65-year-old woman with diabetes and chronic kidney disease-carrying a peritoneal dialysis catheter.
Despite the scarcity of documented cases, the prevalence &incidence of P. lautus infection remain elusive, lacking a dedicated surveillance system or reporting mandate for this organism. Notably, there have been no reported outbreaks of P. lautus infection in humans, suggesting a limited virulence or transmissibility profile. However, its potential impact on public health emerges from its demonstrated resistance to various antibiotics, including penicillin, cephalosporins, and aminoglycosides.
Kingdom: Bacteria
Phylum: Bacillota
Class: Bacilli
Order: Bacillales
Family: Paenibacillaceae
Genus:Paenibacillus
Species:P. lautus
P. lautus, characterized as a gram-positive bacterium, exhibits distinctive features in its structural composition. This endospore-forming rod is typically encountered in diverse environments such as soil, water, and vegetable matter.
Microscopically, P. lautus manifests as a rod with a width ranging from 0.5 to 1.0 µm and a length spanning 4.0 to 7.0 µm. The bacterium is often observed as individual cells or arranged in pairs.
When cultivated, P. lautus forms colonies with specific characteristics. These punctiform colonies are transparent and exhibit a milky white color, featuring an entire margin and a glossy, convex surface. Additionally, the bacterium demonstrates the ability to generate subterminal ellipsoidal spores, a distinctive reproductive feature. The swelling of sporangia during spore formation contributes to the distinct morphology of P. lautus.
P. lautus exhibits antigenic diversity, categorized into two types, A and B, based on serological reactions involving its S-layer protein. This classification enhances our understanding of its immunological characteristics.
The bacterium shares substantial genetic similarities with other members of the Paenibacillus genus, including polymyxa, P. alvei, and P. thiaminolyticus, as well as certain Bacillus species. P. lautus possesses a repertoire of genes encoding enzymes crucial for the degradation of various polysaccharides such as chitin, cellulose, xylan, and starch, reflecting its versatile metabolic capabilities.
The type strain of P. lautus, isolated from the intestinal tract of a child, serves as a reference with culture collection numbers DSM 3035, LMG 11157, NRRL NRS-666, ATCC 43898, CIP 103118, JCM 9073, among others. This strain, characterized as an aerobe and mesophilic gram-positive rod, demonstrates its adaptability to oxygen and moderate temperatures. Notably, the ability to form subterminal ellipsoidal spores adds to its physiological versatility.
The pathogenesis of Paenibacillus lautus in humans remains a subject of limited understanding, given its status as a rare and opportunistic bacterial pathogen capable of causing diverse infections, including wound infection, sepsis, and endocarditis. Several potential factors contribute to its pathogenicity.First, the organism’s ability to produce endospores that exhibit resilience against heat, desiccation, and disinfectants enables it to endure harsh environments.
Additionally, P. lautus can form biofilms, providing a protective shield against antibiotics and the host immune system. The secretion of various virulence proteins, such as proteases, lipases, and hemolysins, further enhances its pathogenic potential. The bacterium’s motility factors, including swimming and swarming capabilities, play a role in facilitating invasion and dissemination.
The pathogenicity of P. lautus may be influenced by host susceptibility, with factors such as underlying health conditions, prosthetic implants, or compromised immunity contributing to its virulence. However, a comprehensive analysis of the molecular mechanisms and host-pathogen interactions underlying P. lautus infection necessitates further research.
Innate defenses include physical barriers like the skin and mucous membranes, complemented by cellular and molecular elements such as phagocytes, complement proteins, cytokines, and antimicrobial peptides. When encountering P. lautus in the bloodstream, phagocytes, particularly neutrophils and macrophages, recognize the bacteria through pattern recognition receptors (PRRs) on their surface. These receptors bind to pathogen-associated molecular patterns (PAMPs) on the bacterial cell wall, initiating phagocytic activation.
Phagocytes then engage in bacterial engulfment and destruction through oxidative and non-oxidative mechanisms, releasing pro-inflammatory cytokines like interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6). These cytokines attract more immune cells to the infection site and induce responses like fever, vasodilation, and increased vascular permeability.
B cells produce antibodies that bind to bacterial antigens, neutralizing them or facilitating phagocytosis and complement activation. Simultaneously, T cells, including helper T cells (Th) and cytotoxic T cells (Tc), are activated. Th cells release cytokines that stimulate various immune cells, while Tc cells eliminate infected cells through the release of perforin and granzymes.
Additionally, the complement system, a group of plasma proteins, is activated in the presence of bacteria. It enhances phagocytic activity, opsonizes P. lautus, and forms membrane attack complexes (MACs) that lyse bacterial cells. The adaptive immune system comes into play with humoral and cellular immunity.
Paenibacillus lautus has been implicated in causing diverse clinical manifestations in individuals with underlying health conditions such as diabetes, coronary artery disease, or those with prosthetic implants. The reported clinical outcomes associated with P. lautus infection include wound infections, cases of sepsis, and even endocarditis. These infections can vary widely in their presentation, with manifestations ranging from paucisymptomatic cases to severe sepsis. The bacterium is often detected in the bloodstream, leading to manifest bacteremia.
Healthcare providers must remain vigilant, especially when dealing with patients who have predisposing factors like diabetes, coronary artery disease, or implanted devices, as they may be more susceptible to P. lautus infections. Timely recognition & appropriate management are paramount in mitigating the impact of such infections, ranging from localized wound issues to potentially life-threatening systemic conditions like sepsis and endocarditis.
Diagnosis tests for P. lautus involve various approaches, ensuring accurate identification of this opportunistic pathogen. Molecular techniques, such as 16S rDNA sequencing, serve as powerful tools for amplifying & sequencing the highly conserved 16S ribosomal RNA gene. This method enables precise identification at the genus and species levels, contributing to the differentiation of P. lautus from other bacterial species.
Another molecular approach, ctpA sequencing, targets the ctpA gene, which encodes a protease involved in sporulation and germination. This specific gene becomes crucial for distinguishing P. lautus from closely related species. By utilizing molecular techniques, healthcare professionals can enhance the accuracy of identification, facilitating targeted and effective treatment strategies.
Complementing molecular methods, conventional biochemical tests play a crucial role in diagnosing P. lautus infections. These tests assess the metabolic and enzymatic activities of the bacteria, including catalase, oxidase, indole, nitrate reduction, and carbohydrate fermentation. The information obtained from these tests provides valuable phenotypic characteristics, reinforcing the confirmation of the bacterial identification.
Individuals should refrain from direct contact with soil, water, and vegetable matter that may harbor P. lautus spores. Protective gloves & clothing should be worn when handling potentially contaminated materials.
It is essential to practice good wound care hygiene. Any wounds or injuries should be promptly cleaned and disinfected to prevent bacterial entry. In the event of signs of infection, such as fever, pain, swelling, or pus formation, individuals should seek immediate medical attention.
Implementing measures to improve waste disposal practices & rodent control helps prevent the attraction and proliferation of rodents that may carry P. lautus-infected ticks.
The epidemiology of Paenibacillus lautus infection still needs to be explored, primarily due to frequent misidentifications as Bacillus species using conventional methods. Limited data gleaned from documented cases shed light on its occurrence, revealing instances predominantly in individuals with underlying health conditions or prosthetic implants.
The first reported case of P. lautus bacteremia dates back to 1996, involving a 69-year-old man with diabetes and coronary artery disease equipped with a prosthetic aortic valve. Since then, only sporadic cases have surfaced globally, with the latest recorded instance in 2019 featuring a 65-year-old woman with diabetes and chronic kidney disease-carrying a peritoneal dialysis catheter.
Despite the scarcity of documented cases, the prevalence &incidence of P. lautus infection remain elusive, lacking a dedicated surveillance system or reporting mandate for this organism. Notably, there have been no reported outbreaks of P. lautus infection in humans, suggesting a limited virulence or transmissibility profile. However, its potential impact on public health emerges from its demonstrated resistance to various antibiotics, including penicillin, cephalosporins, and aminoglycosides.
Kingdom: Bacteria
Phylum: Bacillota
Class: Bacilli
Order: Bacillales
Family: Paenibacillaceae
Genus:Paenibacillus
Species:P. lautus
P. lautus, characterized as a gram-positive bacterium, exhibits distinctive features in its structural composition. This endospore-forming rod is typically encountered in diverse environments such as soil, water, and vegetable matter.
Microscopically, P. lautus manifests as a rod with a width ranging from 0.5 to 1.0 µm and a length spanning 4.0 to 7.0 µm. The bacterium is often observed as individual cells or arranged in pairs.
When cultivated, P. lautus forms colonies with specific characteristics. These punctiform colonies are transparent and exhibit a milky white color, featuring an entire margin and a glossy, convex surface. Additionally, the bacterium demonstrates the ability to generate subterminal ellipsoidal spores, a distinctive reproductive feature. The swelling of sporangia during spore formation contributes to the distinct morphology of P. lautus.
P. lautus exhibits antigenic diversity, categorized into two types, A and B, based on serological reactions involving its S-layer protein. This classification enhances our understanding of its immunological characteristics.
The bacterium shares substantial genetic similarities with other members of the Paenibacillus genus, including polymyxa, P. alvei, and P. thiaminolyticus, as well as certain Bacillus species. P. lautus possesses a repertoire of genes encoding enzymes crucial for the degradation of various polysaccharides such as chitin, cellulose, xylan, and starch, reflecting its versatile metabolic capabilities.
The type strain of P. lautus, isolated from the intestinal tract of a child, serves as a reference with culture collection numbers DSM 3035, LMG 11157, NRRL NRS-666, ATCC 43898, CIP 103118, JCM 9073, among others. This strain, characterized as an aerobe and mesophilic gram-positive rod, demonstrates its adaptability to oxygen and moderate temperatures. Notably, the ability to form subterminal ellipsoidal spores adds to its physiological versatility.
The pathogenesis of Paenibacillus lautus in humans remains a subject of limited understanding, given its status as a rare and opportunistic bacterial pathogen capable of causing diverse infections, including wound infection, sepsis, and endocarditis. Several potential factors contribute to its pathogenicity.First, the organism’s ability to produce endospores that exhibit resilience against heat, desiccation, and disinfectants enables it to endure harsh environments.
Additionally, P. lautus can form biofilms, providing a protective shield against antibiotics and the host immune system. The secretion of various virulence proteins, such as proteases, lipases, and hemolysins, further enhances its pathogenic potential. The bacterium’s motility factors, including swimming and swarming capabilities, play a role in facilitating invasion and dissemination.
The pathogenicity of P. lautus may be influenced by host susceptibility, with factors such as underlying health conditions, prosthetic implants, or compromised immunity contributing to its virulence. However, a comprehensive analysis of the molecular mechanisms and host-pathogen interactions underlying P. lautus infection necessitates further research.
Innate defenses include physical barriers like the skin and mucous membranes, complemented by cellular and molecular elements such as phagocytes, complement proteins, cytokines, and antimicrobial peptides. When encountering P. lautus in the bloodstream, phagocytes, particularly neutrophils and macrophages, recognize the bacteria through pattern recognition receptors (PRRs) on their surface. These receptors bind to pathogen-associated molecular patterns (PAMPs) on the bacterial cell wall, initiating phagocytic activation.
Phagocytes then engage in bacterial engulfment and destruction through oxidative and non-oxidative mechanisms, releasing pro-inflammatory cytokines like interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6). These cytokines attract more immune cells to the infection site and induce responses like fever, vasodilation, and increased vascular permeability.
B cells produce antibodies that bind to bacterial antigens, neutralizing them or facilitating phagocytosis and complement activation. Simultaneously, T cells, including helper T cells (Th) and cytotoxic T cells (Tc), are activated. Th cells release cytokines that stimulate various immune cells, while Tc cells eliminate infected cells through the release of perforin and granzymes.
Additionally, the complement system, a group of plasma proteins, is activated in the presence of bacteria. It enhances phagocytic activity, opsonizes P. lautus, and forms membrane attack complexes (MACs) that lyse bacterial cells. The adaptive immune system comes into play with humoral and cellular immunity.
Paenibacillus lautus has been implicated in causing diverse clinical manifestations in individuals with underlying health conditions such as diabetes, coronary artery disease, or those with prosthetic implants. The reported clinical outcomes associated with P. lautus infection include wound infections, cases of sepsis, and even endocarditis. These infections can vary widely in their presentation, with manifestations ranging from paucisymptomatic cases to severe sepsis. The bacterium is often detected in the bloodstream, leading to manifest bacteremia.
Healthcare providers must remain vigilant, especially when dealing with patients who have predisposing factors like diabetes, coronary artery disease, or implanted devices, as they may be more susceptible to P. lautus infections. Timely recognition & appropriate management are paramount in mitigating the impact of such infections, ranging from localized wound issues to potentially life-threatening systemic conditions like sepsis and endocarditis.
Diagnosis tests for P. lautus involve various approaches, ensuring accurate identification of this opportunistic pathogen. Molecular techniques, such as 16S rDNA sequencing, serve as powerful tools for amplifying & sequencing the highly conserved 16S ribosomal RNA gene. This method enables precise identification at the genus and species levels, contributing to the differentiation of P. lautus from other bacterial species.
Another molecular approach, ctpA sequencing, targets the ctpA gene, which encodes a protease involved in sporulation and germination. This specific gene becomes crucial for distinguishing P. lautus from closely related species. By utilizing molecular techniques, healthcare professionals can enhance the accuracy of identification, facilitating targeted and effective treatment strategies.
Complementing molecular methods, conventional biochemical tests play a crucial role in diagnosing P. lautus infections. These tests assess the metabolic and enzymatic activities of the bacteria, including catalase, oxidase, indole, nitrate reduction, and carbohydrate fermentation. The information obtained from these tests provides valuable phenotypic characteristics, reinforcing the confirmation of the bacterial identification.
Individuals should refrain from direct contact with soil, water, and vegetable matter that may harbor P. lautus spores. Protective gloves & clothing should be worn when handling potentially contaminated materials.
It is essential to practice good wound care hygiene. Any wounds or injuries should be promptly cleaned and disinfected to prevent bacterial entry. In the event of signs of infection, such as fever, pain, swelling, or pus formation, individuals should seek immediate medical attention.
Implementing measures to improve waste disposal practices & rodent control helps prevent the attraction and proliferation of rodents that may carry P. lautus-infected ticks.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
